Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Edesa Biotech › CEO received an award of 2,578 EDSA shares Insider trades
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Apr 1, 2026
Reporting period Not applicable
Filed with the SEC Apr 11, 2026 CEO Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001171843-26-002373
Filed / recorded
Apr 11, 2026, 1:02 AM UTC
Added to OQRO Oct 8, 2026, 2:46 AM UTC
Data quality Verified: identifiers matched exactly
Issuer Edesa Biotech, Inc.
Reporting person Pardeep Nijhawan
Relationship Director, Officer, 10% owner
Officer title Chief Executive Officer
Table Non-derivative (Table I)
Transaction date Apr 1, 2026
Acquired / disposed Acquired (A)
Shares owned after 631,391
Footnotes from the filing Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
Around the same time Insider filing
Traded May 1 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
First insider buy since Mar 2024 Traded Feb 26 · filed 14 days later
Edesa Biotech 's President paid $3.1K out of pocket for Edesa Biotech shares. 1 other person at Edesa Biotech bought some too, in the same month.
Insider buying
Traded Mar 10 · filed 1 day later
The CEO of Edesa Biotech paid $6.6K out of pocket for Edesa Biotech shares. 1 other person at Edesa Biotech bought some too, in the same month.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Feb 13, 2026 Company filing · Form 8-K · Results Reported its results Feb 26, 2026 Insider · 2 people Insiders: 2 purchases (~$36K) Feb 27, 2026 Insider · Their largest buy since 2021 CEO purchased ~$67K of EDSA shares in the open market Mar 2, 2026 Insider · 1 person Insiders: 2 purchases (~$6K) Mar 3, 2026 Insider CEO purchased ~$36K of EDSA shares in the open market Mar 4, 2026 Insider CEO purchased ~$43K of EDSA shares in the open market Mar 5, 2026 Insider CEO purchased ~$39K of EDSA shares in the open market Mar 10, 2026 Insider CEO purchased ~$6.6K of EDSA shares in the open market What came next May 13, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On May 13, 2026, the Board of Directors of Edesa Biotech, Inc. (the “Company”), at the request of Pardeep Nijhawan, the Company’s Chief Executive Officer, approved, pursuant to the terms of the Amended and Restated Employment Agreement, dated August 4, 2023, as amended (the “Employment Agreement”) between the Company and Dr. Nijhawan, that 90% of Dr. Nijhawan’s monthly base salary otherwise payable in cash shall be…” May 14, 2026 Company filing · Form 8-K · Results Reported its results May 27, 2026 Company filing · Form 8-K · Executive change, Shareholder vote Changed a top executive or board member, and held a shareholder vote
“On May 27, 2026, Edesa Biotech, Inc. (the “Company”) held its 2026 Annual General and Special Meeting of Shareholders (the “Annual Meeting”).”